Biopharma Credit PlcBioPharma Credit Investments V (Master) LPBpcr Limited Partnership
Description
On February 26, 2026, UroGen Pharma Ltd. entered into a loan agreement to receive total funding of up to $250 million. The funding is structured in two tranches, with the first tranche of $200 million already provided. The second tranche of $50 million will be accessible upon the Borrower's election by June 30, 2027
Who to call at UroGen Pharma, and when
A new round usually means UroGen Pharma is about to hire and buy. The teams that reach out first get the meeting.
An alert the day UroGen Pharma raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at UroGen Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at UroGen Pharma. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
UroGen Pharma
Location
400 Alexander Park Drive
Princeton, New Jersey, United States
About
UroGen Pharma is a biotech company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated – because patients deserve better options. Our vision is grounded in our RTGel® drug delivery technology, our promising pipeline, and a collaborative drive for bold results.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment UroGen Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
PrincetonBiotechnologyHealthcare